PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10202034-2	1999	Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.	Okadaic Acid	74-86	interleukin 6	Homo sapiens	111-115	
10202034-2	1999	Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.	Okadaic Acid	74-86	nuclear factor kappa B subunit 1	Homo sapiens	175-185	
10202034-2	1999	Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.	Okadaic Acid	74-86	mitogen-activated protein kinase 3	Homo sapiens	240-246	
10202034-2	1999	Freshly isolated monocytes treated with the protein phosphatase inhibitor okadaic acid secreted high levels of IL-6 protein, which coincided with enhanced binding activity of NF-kappa B as well as with phosphorylation and activation of the ERK1/2 and JNK proteins.	Okadaic Acid	74-86	mitogen-activated protein kinase 8	Homo sapiens	251-254	
10202034-3	1999	The ERK pathway-specific inhibitor PD98059 inhibited IL-6 secretion from monocytes.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	35-42	mitogen-activated protein kinase 1	Homo sapiens	4-7	
10202034-3	1999	The ERK pathway-specific inhibitor PD98059 inhibited IL-6 secretion from monocytes.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	35-42	interleukin 6	Homo sapiens	53-57	
10202034-5	1999	By using PD98059, we demonstrated that the Raf1/MEK1/ERK1/2 pathway did not affect the DNA binding of NF-kappa B but, rather, acted at the level of transcriptional activity of NF-kappa B.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	9-16	Raf-1 proto-oncogene, serine/threonine kinase	Homo sapiens	43-47	
10202034-5	1999	By using PD98059, we demonstrated that the Raf1/MEK1/ERK1/2 pathway did not affect the DNA binding of NF-kappa B but, rather, acted at the level of transcriptional activity of NF-kappa B.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	9-16	mitogen-activated protein kinase kinase 1	Homo sapiens	48-52	
10202034-5	1999	By using PD98059, we demonstrated that the Raf1/MEK1/ERK1/2 pathway did not affect the DNA binding of NF-kappa B but, rather, acted at the level of transcriptional activity of NF-kappa B.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	9-16	mitogen-activated protein kinase 3	Homo sapiens	53-59	
10202034-5	1999	By using PD98059, we demonstrated that the Raf1/MEK1/ERK1/2 pathway did not affect the DNA binding of NF-kappa B but, rather, acted at the level of transcriptional activity of NF-kappa B.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	9-16	nuclear factor kappa B subunit 1	Homo sapiens	176-186	
10202034-7	1999	We conclude that okadaic acid-induced IL-6 gene expression is at least partly mediated through the ERK1/2 and JNK pathway-dependent activation of NF-kappa B transcriptional capacity.	Okadaic Acid	17-29	interleukin 6	Homo sapiens	38-42	
10202034-7	1999	We conclude that okadaic acid-induced IL-6 gene expression is at least partly mediated through the ERK1/2 and JNK pathway-dependent activation of NF-kappa B transcriptional capacity.	Okadaic Acid	17-29	mitogen-activated protein kinase 3	Homo sapiens	99-105	
10202034-7	1999	We conclude that okadaic acid-induced IL-6 gene expression is at least partly mediated through the ERK1/2 and JNK pathway-dependent activation of NF-kappa B transcriptional capacity.	Okadaic Acid	17-29	mitogen-activated protein kinase 8	Homo sapiens	110-113	
10202034-7	1999	We conclude that okadaic acid-induced IL-6 gene expression is at least partly mediated through the ERK1/2 and JNK pathway-dependent activation of NF-kappa B transcriptional capacity.	Okadaic Acid	17-29	nuclear factor kappa B subunit 1	Homo sapiens	146-156